Skip to main content
Caplight Logo









Heepsy

Heepsy

Private
BilbaoEnterprise Softwarehttps://heepsy.com

Last Round

Accelerator

May 29, 2018

Total Funding Raised

$180,000

Company Overview

Heepsy operates in Enterprise Software and is based in Bilbao. Its latest recorded funding round was an Accelerator round in May 2018.

Heepsy is a marketing technology company that provides an influencer marketing platform designed to help brands and agencies find, analyze, and manage campaigns with social media creators.

Sector

Enterprise Software

Verticals

Influencer Marketing, Marketing, Creator Economy, CRM, Digital Advertising

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Heepsy Comparables

Compare Heepsy with similar companies based on industry and business-model similarity.

Heepsy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HypeAuditor
89%
Influencity
88%
Influencer Hero
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Heepsy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 29, 2018
SeedMay 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Heepsy Investors

Notable investors and investment history

Heepsy investors
InvestorRounds
Viriditas VenturesSeed
Google for StartupsAccelerator
MassChallenge IsraelAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 7, 2024

    Grew 133% QoQ, from 3 to 7 employees.

  • Nov 23, 2023

    Grew 75% QoQ, from 4 to 7 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Heepsy Filings

Explore SEC and related filing metadata, where available.

Heepsy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Heepsy's valuation, stock price, and market status.

Is Heepsy a public or private company?

Heepsy is a private company.

What is the current stock price of Heepsy?

Heepsy is a private company, so its shares have no public market price. Caplight tracks Heepsy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Heepsy worth (valuation)?

Valuation information for Heepsy is not publicly available.

Can I buy Heepsy stock?

Heepsy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Heepsy's last funding round?

Heepsy's most recent funding round was Accelerator on May 29, 2018.

Who are the main investors in Heepsy?

Key investors in Heepsy include Viriditas Ventures, Google for Startups, MassChallenge Israel.

Will Heepsy IPO soon?

No public IPO plans have been announced for Heepsy.

How can I track Heepsy secondary market activity?

Caplight tracks bids, offers, and trades in Heepsy's shares on secondary markets.

Firmographic Details

HeadquartersBilbao
Employee Range8
Year Founded2016
Last FundingMay 29, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?